Skip to content

Drug interactions

Eltrombopag + Ketorolac intranasal

Severity: Moderate

Eltrombopag and Ketorolac intranasal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ketorolac is partly glucuronidated, and eltrombopag inhibits UGT enzymes in vitro, so exposure could rise, though the effect is unproven. Ketorolac also impairs platelet function and can cause GI bleeding and renal injury, which is a concern in thrombocytopenia.

What this interaction means in plain words

Eltrombopag and Ketorolac intranasal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Possible UGT inhibition by eltrombopag, plus additive bleeding risk from ketorolac's antiplatelet effect.

What to do

Avoid ketorolac in patients with significant thrombocytopenia and use a non-NSAID analgesic. If used, keep treatment short and monitor for bleeding and renal function.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eltrombopag and Ketorolac intranasal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eltrombopag with Ketorolac intranasal?

MediHelp rates the interaction as moderate. Eltrombopag and Ketorolac intranasal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ketorolac is partly glucuronidated, and eltrombopag inhibits UGT enzymes in vitro, so exposure could rise, though the effect is unproven. Ketorolac also impairs platelet function and can cause GI bleeding and renal injury, which is a concern in thrombocytopenia.

How serious is the interaction between Eltrombopag and Ketorolac intranasal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid ketorolac in patients with significant thrombocytopenia and use a non-NSAID analgesic. If used, keep treatment short and monitor for bleeding and renal function.

What other medicines interact with Eltrombopag?

MediHelp also lists interactions of Eltrombopag with, for example, Alpelisib, Aluminum hydroxide, Amobarbital. The full list is on the Eltrombopag page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in